MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 125 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $40,000 | -97.7% | 4,694 | -96.6% | 0.00% | -100.0% |
| Q2 2015 | $1,710,000 | -4.0% | 138,297 | -7.8% | 0.00% | 0.0% |
| Q1 2015 | $1,782,000 | -29.6% | 150,049 | -34.2% | 0.00% | -25.0% |
| Q4 2014 | $2,530,000 | +46.6% | 228,103 | +16.0% | 0.00% | +33.3% |
| Q3 2014 | $1,726,000 | +150.9% | 196,622 | +69.0% | 0.00% | +200.0% |
| Q2 2014 | $688,000 | +34300.0% | 116,322 | +23883.9% | 0.00% | – |
| Q3 2013 | $2,000 | +100.0% | 485 | +385.0% | 0.00% | – |
| Q2 2013 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 514,853 | $2,595,000 | 2.23% |
| GARRISON BRADFORD & ASSOCIATES INC | 98,001 | $494,000 | 0.48% |
| Catalyst Capital Advisors LLC | 380,896 | $1,920,000 | 0.44% |
| Knoll Capital Management, LLC | 160,585 | $809,000 | 0.42% |
| Tekla Capital Management LLC | 757,050 | $3,816,000 | 0.38% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 524,800 | $2,645,000 | 0.13% |
| Integre Asset Management, LLC | 103,493 | $522,000 | 0.12% |
| CAMBRIDGE TRUST CO | 220,003 | $1,109,000 | 0.10% |
| JAMISON EATON & WOOD INC /NJ | 62,782 | $316,000 | 0.09% |
| STONERIDGE INVESTMENT PARTNERS LLC | 88,304 | $445,000 | 0.09% |